Tachykinin receptor antagonists in irritable bowel syndrome

Current Opinion in Investigational Drugs

Volumn 3, Issue 4, 2002, Pages 589-601

  Lecci, Alessandro ^a   Valenti, Claudio ^a   Maggi, Carlo Alberto ^a  

^a Pharmacology Department   (Italy)

Author keywords

Acetylcholine; Inflammation; Intestine; Irritable bowel syndrome; NK1; NK2; NK3; Stress; Tachykinins; Viscera l pain

Indexed keywords

ATROPINE; CAPSAICIN; GUANETHIDINE; INDOMETACIN; LANEPITANT; NALOXONE; NEPADUTANT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ B; PREPROTACHYKININ; PREPROTACHYKININ A; PREPROTACHYKININ B; PREPROTACHYKININ C; SENKTIDE; SEROTONIN 3 ANTAGONIST; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST; TAK 637; TROPISETRON; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; YOHIMBINE;

CELL SECRETION; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; CONSTIPATION; DIAGNOSTIC VALUE; DIARRHEA; DRUG INHIBITION; DRUG MECHANISM; DRUG TARGETING; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TRACT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTERNEURON; INTESTINE CONTRACTION; INTESTINE INNERVATION; INTESTINE MOTILITY; IRRITABLE COLON; MAST CELL DEGRANULATION; MOTOR DYSFUNCTION; MOTOR NERVE; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SENSITIZATION; SENSORIMOTOR FUNCTION; SENSORY NERVE; SIDE EFFECT; STRESS; VISCERAL PAIN; ANIMAL; DRUG ANTAGONISM; GASTROINTESTINAL MOTILITY; INTESTINE; METABOLISM; VISCERA;

ANIMAL; CLINICAL TRIALS; COLONIC DISEASES, FUNCTIONAL; GASTROINTESTINAL MOTILITY; HUMAN; INFLAMMATION; INTESTINES; RECEPTORS, TACHYKININ; STRESS; VISCERA; ANIMALS; HUMANS;

EID: 0035988860     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (154)

1. Rome II: A multinational consensus document on functional gastrointestinal disorders
2. British society of gastroenterology guidelines for the management of irritable bowel syndrome
3. Pathophysiology in irritable bowel syndrome
4. Receptors and transmission in the brain-gut axis: Potential for novel theraapies. I. Receptors on visceral afferents
5. Efficacy and safety of alosetron in women with irritable bowel syndrome: A placebo-controlled trial
6. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
7. Tachykinins in the gut. Part I. Expression, release and motor function
8. Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum
9. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis
10. The effects of tachykinins on inflammatory and immune cells
11. Anatomy and physiology of the enteric nervous system
12. Neurochemical coding of myenteric neurons in the guinea-pig ileum
13. Distribution of neurokinin A-like and neurokinin B-like immunoreactivity in human peripheral tissue
14. Distribution and localization of neurokinin A-like immunoreactivity and neurokinin B-like immunoreactivity in rat peripheral tissue
15. Both substance P and its receptor are expressed in mouse intestinal T lymphocytes
16. Cellular sites of expression of the neurokinin-1 receptor in the rat gastrointestinal tract
17. 3 receptors in the rat gastrointestinal tract
18. 1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract
19. Distribution of neurokinin-2 receptors in the guinea-pig gastrointestinal tract
20. 1 tachykinin receptors in the guinea-pig small intestine
21. 1, tachykinin receptorrs on motor neurons supplying the circular muscle of guinea-pig small and large intestine
22. 1 tachykinin receptor on muscle and epithelia in guinea-pig intestine
23. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine
24. 2 tachykinin receptors and substance P in nerve endings of the guinea-pig ileum
25. 3 tachykinin receptor localization and tachykinin distribution in the ileum of the mouse
26. Localization of neurokinin 3 (NK3) receptor immunoreactivity in the rat gastrointestinal tract
27. 3 tachykinin receptors in the guinea-pig ileum revealed by specific binding of fluorescently labelled agonists
28. Intestinal peristalsis associated with release of immunoreactive substance P
29. Identification of neurotransmitters regulating intestinal peristaltic reflex in humans
30. Intraduodenal neuropeptide levels, but not plasma levels, vary in cyclic fashion with the migrating motor complex
31. Sequential activation of the triple excitatory transmission to the circular muscle of guinea-pig colon
32. Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus
33. Evidence for the involvement of ATP, but not of VIP/PACAP or nitric oxide, in the excitatory effect of capsaicin in the small intestine
34. 2 receptors in intestinal peristalsis
35. Substance P stimulates and inhibits intestinal peristalsis via distinct receptors
36. 2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro
37. Substance P: A potent inhibitor of the canine small intestine in vivo
38. 1 receptor-mediated inhibitory responses in the guinea-pig small intestine
39. Involvement of nitric oxide in the substance P-induced inhibition of intestinal peristalsis
40. 1 receptor agonists in the guinea-pig small intestine
41. 2 type of neurokinin receptor
42. 2 receptor selective antagonist MEN10627 in rat small intestine
43. 2 receptors in rats
44. Tachykinin receptors mediate atropine-resistant rat duodenal contractions in vivo
45. 2 receptors in gastric barosensitivity and in experimental ileus in rats
46. 2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine
47. 2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum
48. Tachykinin-dependent and independent components of peristalsis in the guinea pig isolated distal colon
49. 2 tachykinin receptors to propulsion in the rabbit distal colon
50. 3 tachykinin receptors to propulsion in the rabbit isolated distal colon
51. In vivo evidence for the involvement of tachykinin NK3 receptors in the hexamethonium-resistant inhibitory transmission in the rat colon
52. 3 receptor agonists in isolated guinea-pig colon
53. Tachykinins and reflexly evoked atropine-resistant motility in the guinea-pig colon in vivo
54. Role of tachykinins in castor oil diarrhea in rats
55. 2 receptors and enhancement of cholinergic transmission in the inflamed rat colon: An in vivo motility study
56. 2 receptor antagonist are altered by intestinal inflammation in rodent models
57. 2 receptor antagonist in the guinea-pig and human colon
58. 2 receptors in atropine-resistant colonic propulsion in anaesthetized guinea-pigs
59. 2 receptors mediate release of non-adrenergic non-cholinergic inhibitory transmitters in the circular muscle of guinea-pig colon
60. 2 selective agonist [βAla8]neurokinin A-(4-10)
61. Effects of neurokinins on human colonic motility
62. +-induced contractility in rabbit colitis
63. 1 receptors of the electrically evoked release of acetylcholine from guinea-pig myenteric neurons
64. 2 receptors modulate resting tone in rat isolated small intestine
65. 2 receptors in the modulation of spontaneous motility in rat proximal colon
66. 2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation
67. Irritable bowel syndrome: New agents targeting serotonin receptor subtypes
68. 4 receptors in the guinea-pig ileum
69. Investigation into the 5-hydroxytryptamine-induced atropine-resistant neurogenic contraction of the guinea-pig proximal colon
70. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea-pig intestine
71. 3 receptor mediated inhibition of 5-hydroxytryptamine release from vascularly perfused small intestine of the guinea-pig
72. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation
73. The putative role of inflammation in the irritable bowel syndrome
74. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome
75. Tachykinins increase vascular permeability in the gastrointestinal tract of the rat
76. Comparative effects of non peptide tachykinin receptor antagonists on experimental gut inflammation in rats and guinea-pigs
77. Protective effect of the tachykinin NK2 receptor antagonist nepadutant in acute rectocolitis induced by diluted acetic acid in guinea-pigs
78. Neurokinin mediation of edema and inflammation
79. 1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs
80. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice
81. 1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats
82. 1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation
83. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis
84. Pharmacological characterization of neurokinin receptors mediating anion secretion in rat descending colon mucosa
85. 2 receptor mediates contraction and ion transport in rat colon by different mechanisms
86. Different tachykinin receptors mediate chloride secretion in the distal colon through activation of submucosal neurones
87. 3 receptor-mediated colonic ion transport in the guinea-pig
88. Neural components of distension-evoked responses in the guinea-pig distal colon
89. Cellular pathways mediating tachykinin-evoked secretomotor responses in guinea-pig ileum
90. Neuroimmune regulation of colonic secretion in guinea-pigs
91. 1 antagonist SR-140333: Assessment of potential anti-diarrhoeal activity in food alergy and inflammatory bowel disease
92. 2 receptors in rat colonic hypersecretion induced by interleukin 1β: Role of nitric oxide
93. Rectal distension-induced colonic net water secretion in rats involves tachykinins, capsaicin sensory, and vagus nerves
94. CP-96345, a substance P antagonist, inhibits rat intestinal response to clostridium difficile toxin A but not cholera toxin
95. Neurokinin 1 and 2 receptors mediate cholera toxin secretion in rat jejunum
96. Extrinsic surgical denervation inhibits Clostridium difficile toxin A-induced enteritis in rats
97. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells
98. Effects of substance P on human colonic mucosa
99. 1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation
100. Alterations of intestinal motor responses to various stimuli after Nippostrongylus brasiliensis infection in rats: Role of mast cells
101. Effects of tachykinin receptor antagonists on rat jejunal distension pain response
102. Development and sequels of intestinal inflammation in nematode-infected rats: Role of mast cells and capsaicin-sensitive afferents
103. Terminal ileal mucosal mast cells in irritable bowel syndrome
104. Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis
105. Increased mast cells in the irritable bowel syndrome
106. Effect of ovarian hormones on intestinal mast cell reactivity to substance P
107. Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats
108. 1 receptor expression in rat peritoneal mast cells
109. Stem cell factor and interleukin-4 increase the responsiveness of mast cells to substance P
110. Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease
111. Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P
112. Human skin mast cells produce TNF-alpha by substance P
113. Involvement of tachykinin receptors in sensitization to cow's milk proteins in guinea-pigs
114. Chronic stress impairs rat growth and jejunal epithelial barrier function: Role of mast cells
115. Acute stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells
116. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo
117. 2 receptors in normal and altered rectal sensitivity in rats
118. Impact of corticotropin releasing hormone in normal controls and patients with irritable bowel syndrome
119. 1) antagonists
120. Anxiolytic activity of tachykinin receptor antagonists in the mouse light-dark box
121. Effects of central administration of tachykinin receptor agonists and antagonists on plus maze behavior in mice
122. 2 receptor antagonist on emotional processes in rodents
123. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects
124. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
125. Rectal afferent function in patients with inflammatory and functional intestinal disorders
126. Perceptual responses in patients with inflammatory and functional bowel disease
127. Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome
128. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome
129. Pathobiology of visceral pain: Molecular mechanisms and therapeutic implications. IV. Visceral afferent contributions to the pathobiology of visceral pain
130. Colorectal distension as a noxious visceral stimulus: Physiologic and pharmacologic characterization of pseudoaffective reflexes in the rat
131. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats
132. Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: Role of CGRP
133. Role of neurokinin 3 receptors on responses to colorectal distension in the rat: Electrophysiological and behavioral studies
134. Intestinal inflammation and activation of sensory nerve pathways: A functional and morphological study in nematode infected rat
135. Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia
136. 1 receptor gene expression is related to pain in chronic pancreatitis
137. 1 receptor gene
138. 2 receptors
139. 2 receptor antagonist, MEN11420 on proto-oncogene expression following experimental colitis
140. 2 receptors
141. Chronic low-level administration of diquat increases the nociceptive response to gastric distension in rats: Role of mast cells and tachykinin receptor activation
142. 1 receptors in the periphery
143. Role of peripheral N-methyl-D-Aspartate (NMDA) receptors in visceral nociception in rats
144. 3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord
145. 3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart
146. 3 receptors and vagal afferent fibres
147. 3 receptors and afferent fibers in the effect of mast cell degranulation on colonic motility in rats
148. 3 receptor antagonists in modulation of visceral hypersensitivity
149. Mast cell degranulation induces delayed rectal allodynia in rats role of histamine and 5-HT
150. Chemical signaling from colonic smooth muscle cells to DRG neurons in culture
151. Calcium waves in colonic myocytes produced by mechanical and receptor-mediated stimulation
152. 2 receptors in producing fast and slow atropine-resistant neurotransmission to the circular muscle of the guinea-pig colon
153. 2 receptors mediate neurally induced contraction of human sigmoid circular smooth muscle
154. Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy